Molecular Formula | C13H16N2O2S |
Molar Mass | 264.34 |
Solubility | DMSO: ≥ 32 mg/mL |
Storage Condition | under inert gas (nitrogen or Argon) at 2–8 °C |
In vitro study | The compound AX20017 inhibitor is bound deep within a narrow pocket formed by the inter lobe cleft of the PknG domain. The main chain Glu233:O and Val235:NH of PknG form hydrogen bonds with AX20017.AX20017 results in mycobacterial transfer to lysosomes and killing of the mycobacteria. AX20017 does not affect the human kinases, whereas the activity of PknG is effectively inhibited. AX20017 does not affect cellular morphology, membrane ruffling, or macropinocytosis. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.783 ml | 18.915 ml | 37.83 ml |
5 mM | 0.757 ml | 3.783 ml | 7.566 ml |
10 mM | 0.378 ml | 1.891 ml | 3.783 ml |
5 mM | 0.076 ml | 0.378 ml | 0.757 ml |
biological activity | AX20017 is a small molecule inhibitor of protein kinase G (PknG) with an IC50 value of 0.39 μm. |
Target | IC50: 0.39 μm (PknG) |